This report presents a comprehensive analysis of the US Endoscopy Capsules market, including size, share, drivers, trends, opportunities, and revenue forecasts from 2020 to 2035. Key developments influencing market growth and regional shares for 2025 are also highlighted.
The economic impact of tariffs on "US Endoscopy Capsules".
US Endoscopy Capsules Market Growth Drivers
Rising prevalence of gastrointestinal diseases is a significant driver for the US endoscopy capsules market. The growing incidence of conditions such as Crohn’s disease, gastrointestinal bleeding, and colorectal cancers has increased the demand for minimally invasive diagnostic procedures. Medtronic plc has reported a steady uptake of its PillCam™ capsule endoscopy solutions, attributed to the improved patient comfort and non-invasive nature of the technology, which is now being widely adopted in ambulatory care settings.
Continuous technological advancements are propelling the market forward. Companies like Olympus Corporation have introduced advanced capsules capable of higher image resolution and longer battery life, enhancing diagnostic accuracy and reducing the need for repeat procedures. This progress is also enabling real-time wireless data transmission, allowing physicians to rapidly assess patient results, thus streamlining workflow efficiency in healthcare facilities.
US Endoscopy Capsules Market Trends
Artificial intelligence (AI) integration in capsule endoscopy is rapidly becoming a key trend. Companies such as IntroMedic are pioneering AI-powered platforms that automatically detect and classify lesions, reducing manual review time for physicians and helping standardize diagnostic accuracy across diverse clinical environments.
Expanding indications beyond the small bowel are being observed. For instance, CapsoVision has successfully broadened clinical applications of their capsule endoscopy devices to include esophageal and colon imaging. This trend not only diversifies the potential patient base but also increases the usage frequency of capsule endoscopy systems in outpatient settings.
US Endoscopy Capsules Market Opportunity
The shift towards at-home diagnostics for GI disorders presents an emerging opportunity. Companies like Medtronic are developing remote monitoring and reporting capabilities for capsule endoscopy, enabling patient convenience and expanding access to underserved populations. Partnerships with telehealth platforms promise further market expansion in this direction.
There is growing potential for partnerships with insurance providers to improve reimbursement policies for capsule endoscopy procedures. Enhanced coverage will likely increase adoption among healthcare providers and patients, making this a lucrative avenue for market players.
US Endoscopy Capsules Market Revenue (USD Million), 2020-2035
The US endoscopy capsules market has demonstrated steady growth from 2020, with revenue increasing from $370 million to a projected $1,265 million by 2035. Early years showed moderate adoption influenced by awareness campaigns and initial reimbursement approvals. From 2025 onward, revenue picks up significantly, largely attributable to expanding indications, wider insurance coverage, and integration of advanced imaging and AI technologies. By 2030, market revenues cross $900 million as patient and physician acceptance surges. This trajectory underscores the sustained value and ongoing innovations within the market landscape.
US Endoscopy Capsules Market by Regions Share (%), 2025
In 2025, the US endoscopy capsules market is dominated by the South region, contributing 35% to total market share. The West follows with 26%, driven by advanced healthcare infrastructure and typically faster adoption of new diagnostic technologies. The Midwest represents 18%, reflecting solid penetration in hospital networks and clinics. The Northeast accounts for a 14% share, while other regions collectively comprise 7%. These shares illustrate geographical disparities in technology adoption and reimbursement environments across the United States.
US Endoscopy Capsules Recent Developments
In May 2024, Medtronic launched its PillCam™ Genius, featuring advanced AI-based detection for small bowel lesions. The company collaborated with leading hospital chains to pilot this technology, focusing on improving detection rates and reducing procedure times. This launch aligns with Medtronic’s strategy of expanding its digital GI product portfolio in the US.
In March 2024, CapsoVision received expanded FDA clearance to market its CapsoCam Plus for colon imaging. The new indication allows physicians to diagnose and monitor both upper and lower GI tract conditions using a single device, thus supporting broader clinical utility and improving return on investment for healthcare providers.
In February 2024, Olympus Corporation announced a strategic partnership with a major US telemedicine supplier to integrate capsule endoscopy data into remote patient monitoring platforms. This collaboration aims to extend the reach of capsule-based diagnostics to rural and remote patient populations, furthering access and convenience.
Press Releases